12/08/2025 | Press release | Distributed by Public on 12/08/2025 05:45
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
Appointment of Perry A. Bernocchi as Executive Vice President, Chief Operating Officer
On December 4, 2025, Owens & Minor, Inc. (the "Company") appointed Perry A. Bernocchi, age 67, Executive Vice President, Chief Operating Officer of the Company, effective December 5, 2025. Since March 2023, Mr. Bernocchi has served as Executive Vice President and Chief Executive Officer of the Company's Patient Direct segment. Biographical information regarding Mr. Bernocchi is set forth in the Company's annual report on Form 10-K, filed with the U.S. Securities and Exchange Commission on February 28, 2025, and such information is incorporated by reference herein.
Mr. Bernocchi's compensation and the terms of his employment with the Company remain unchanged. Mr. Bernocchi is not a party to any transaction, and there is no currently proposed transaction with Mr. Bernocchi, that is required to be disclosed pursuant to Item 404(a) of Regulation S-K.There are no family relationships between Mr. Bernocchi and any of the Company's directors or executive officers. Mr. Bernocchi is not a party to any arrangement or understanding regarding his selection as an officer.
Item 7.01. Regulation FD Disclosure.
Effective December 31, 2025, Jennifer Stone, Executive Vice President, Chief Human Resources Officer (CHRO), will leave the Company. Upon Ms. Stone's departure, the CHRO position will be eliminated, and Heath Galloway, Executive Vice President, General Counsel & Corporate Secretary, will add oversight of the human resources function to his current responsibilities.
In accordance with General Instruction B.2 of Form 8-K,the information in this Item 7.01 shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.